MicroRNA-17-5p, a novel endothelial cell modulator, controls vascular re-endothelialization and neointimal lesion

Xiaopei Liu1, Jing Chen1, Gen Liu1

  • 1Department of Cardiology, Cardiovascular Research Institute, Hubei Key Laboratory of Cardiology, 117921Renmin Hospital of Wuhan University, Wuhan, China.

Vascular
|December 27, 2021
PubMed
Abstract

Insights

MicroRNA-17-5p (miR-17-5p) regulates vascular remodeling. Inhibiting miR-17-5p promotes re-endothelialization and reduces neointimal formation, offering a therapeutic strategy for vascular repair.

Area of Science:

  • Vascular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNA-17-5p (miR-17-5p) functions in tumorigenesis are known, but its role in arterial endothelial cells (ECs) and vascular remodeling remains unexplored.
  • Vascular remodeling is a critical process in cardiovascular health and disease, yet specific molecular regulators are not fully understood.

Purpose of the Study:

  • To investigate the impact of miR-17-5p modulation on arterial endothelial cell function and vascular remodeling.
  • To elucidate the underlying molecular mechanisms involving VEGFA and VEGFR2.

Main Methods:

  • Quantitative RT-PCR to assess miR-17-5p expression.
  • Gain- and loss-of-function studies in human coronary artery endothelial cells (HCAECs).
  • In vivo validation in a rat carotid artery balloon injury model, including morphometric analysis and molecular assays.

Main Results:

  • miR-17-5p expression is upregulated in injured vascular walls and ECs.
  • Overexpression of miR-17-5p inhibits EC proliferation and migration; knockdown enhances these functions by regulating VEGFA and VEGFR2.
  • Downregulation of miR-17-5p promotes re-endothelialization and attenuates neointimal formation in vivo.

Conclusions:

  • miR-17-5p plays a significant role in regulating endothelialization and vascular remodeling.
  • Targeting miR-17-5p offers a promising therapeutic strategy for modulating vascular repair processes.